REQUEST A DEMO
Total
USD $0.00
Search more companies

Farmabion del Ecuador C.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Farmabion del Ecuador C.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Farmabion del Ecuador C.A. is based in Ecuador. The head office is in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on January 22, 2014. 22 (2023) employees currently work for Farmabion del Ecuador C.A.. The company’s latest financial report indicates a net sales revenue increase of 54.18% in 2023. Its’ total assets recorded a growth of 45.06%. The net profit margin of Farmabion del Ecuador C.A. decreased by 0.23% in 2023.

Headquarters
Boulevar Naciones Unidas E2-30, Metropolitan Piso 5 Bldg. , Floor 512
Quito; Pichincha;

Contact Details: Purchase the Farmabion del Ecuador C.A. report to view the information.

Basic Information
Total Employees:
Purchase the Farmabion del Ecuador C.A. report to view the information.
Outstanding Shares:
Purchase the Farmabion del Ecuador C.A. report to view the information.
Registered Capital:
Purchase the Farmabion del Ecuador C.A. report to view the information.
Incorporation Date:
January 22, 2014
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Subsidiaries
Farmabion del Ecuador C.A.
1%
Company Performance
Financial values in the chart are available after Farmabion del Ecuador C.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
54.18%
Total operating revenue
53.05%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
31.23%
Total assets
45.06%
Total equity
22.81%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-0.23%
Return on Equity (ROE)
-12.17%
Debt to Equity Ratio
-3.44%
Quick Ratio
0.1%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?